1. Home
  2. LKFN vs GENB Comparison

LKFN vs GENB Comparison

Compare LKFN & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Financial Corporation

LKFN

Lakeland Financial Corporation

HOLD

Current Price

$62.49

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$15.64

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LKFN
GENB
Founded
1872
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
2009
2026

Fundamental Metrics

Financial Performance
Metric
LKFN
GENB
Price
$62.49
$15.64
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$67.00
$23.20
AVG Volume (30 Days)
139.4K
476.8K
Earning Date
04-27-2026
05-11-2026
Dividend Yield
3.49%
N/A
EPS Growth
10.47
N/A
EPS
2.17
N/A
Revenue
$985,000.00
N/A
Revenue This Year
$15.50
N/A
Revenue Next Year
$5.51
$16.58
P/E Ratio
$28.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.36
$11.00
52 Week High
$69.38
$18.18

Technical Indicators

Market Signals
Indicator
LKFN
GENB
Relative Strength Index (RSI) 53.00 59.66
Support Level $57.90 $11.82
Resistance Level $63.27 $16.75
Average True Range (ATR) 1.15 0.84
MACD -0.08 0.18
Stochastic Oscillator 51.59 98.18

Price Performance

Historical Comparison
LKFN
GENB

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare. The company's revenue is derived from the business of banking.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: